Intelligence / Healthtech / PMA Approvals / Abbott Medical
Abbott Medical
4 Sept 2026: Device change approved (PMA) · TactiFlex Duo Ablation Catheter, Sensor Enabled (A-TFDM-D, A-TFDM-F, A-TFDM-J, A-TFDM-DD, A-TFDM-DF, A-TFDM-FF, A-TFDM. Recorded in the openFDA device PMA data.
- Decided
- 4 Sept 2026
- Device
- TactiFlex Duo Ablation Catheter, Sensor Enabled (A-TFDM-D, A-TFDM-F, A-TFDM-J, A-TFDM-DD, A-TFDM-DF, A-TFDM-FF, A-TFDM
- Specialty
- Cardiovascular
- Type
- Supplement (Panel Track)
- Reason
- Change Design/Components/Specifications/Material
- Reference
- P220013 S028
- Location
- Plymouth, MN
A PMA approval is a high-risk device launch: reimbursement, distribution, clinical training and sales hires follow.
- Cardiovascular leads with 53 of 120, then Pathology (15).
- 35 added in the 30 days to 18 Nov 2026.
Find the decision makers at Abbott Medical
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
Across AOS Research
Other records for Abbott Medical in our registers.
More in Cardiovascular
PMA Approvals
Source: openFDA device PMA data, data to 18 Nov 2026. Class III devices approved by FDA: original approvals and supplements that change the device (180-day, panel-track and special tracks). 30-day manufacturing notices are left out. AOS shows what the public record says; it does not verify or endorse the company.